Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C085755 |
4-(1H-imidazol-4-ylmethyl)piperidine |
4-(1H-imidazol-4-ylmethyl)piperidine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
C085755 |
4-(1H-imidazol-4-ylmethyl)piperidine |
4-(1H-imidazol-4-ylmethyl)piperidine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D000082 |
Acetaminophen |
Acetaminophen affects the expression of SLC22A3 mRNA | affects expression | 17562736
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of SLC22A3 protein | affects expression | 20106945
|
D000643 |
Ammonium Chloride |
Ammonium Chloride affects the expression of SLC22A3 mRNA | affects expression | 16483693
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in decreased expression of SLC22A3 mRNA | decreases expression | 20106945
|
C006780 |
bisphenol A |
bisphenol A results in increased expression of SLC22A3 mRNA | increases expression | 18180321
|
C105826 |
BU 224 |
BU 224 inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
C105826 |
BU 224 |
BU 224 inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
C086108 |
clobenpropit |
clobenpropit inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
C086108 |
clobenpropit |
clobenpropit inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D003345 |
Corticosterone |
Corticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D016572 |
Cyclosporine |
Cyclosporine results in decreased expression of SLC22A3 mRNA | decreases expression | 20106945
|
D019259 |
Lamivudine |
SLC22A3 protein results in increased uptake of Lamivudine | increases uptake | 19141712
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of SLC22A3 mRNA | decreases expression | 18042831
|
C103851 |
disprocynium 24 |
disprocynium 24 inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
C103851 |
disprocynium 24 |
disprocynium 24 inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D004958 |
Estradiol |
Estradiol results in decreased expression of SLC22A3 mRNA | decreases expression | 20106945
|
D006632 |
Histamine |
Histamine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D006632 |
Histamine |
Histamine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
4-(1H-imidazol-4-ylmethyl)piperidine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
BU 224 inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
clobenpropit inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
Corticosterone inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
disprocynium 24 inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
Histamine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
Papaverine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
Phentolamine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium | increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
thioperamide inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
trimazosin inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
4-(1H-imidazol-4-ylmethyl)piperidine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
BU 224 inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
clobenpropit inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
disprocynium 24 inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
Histamine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
Papaverine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
Phentolamine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium | increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
thioperamide inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015655 |
1-Methyl-4-phenylpyridinium |
trimazosin inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D015735 |
Mifepristone |
Mifepristone results in decreased expression of SLC22A3 mRNA | decreases expression | 17584828
|
D017239 |
Paclitaxel |
SLC22A3 protein affects the susceptibility to Paclitaxel | affects response to substance | 16217747
|
D017239 |
Paclitaxel |
Paclitaxel results in increased expression of SLC22A3 mRNA | increases expression | 15585946
|
C041786 |
palm oil |
palm oil results in decreased expression of SLC22A3 mRNA | decreases expression | 18042831
|
D010208 |
Papaverine |
Papaverine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D010208 |
Papaverine |
Papaverine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D010634 |
Phenobarbital |
NR1I3 protein affects the reaction [Phenobarbital results in increased expression of SLC22A3 mRNA] | affects reaction|increases expression | 19482888
|
D010634 |
Phenobarbital |
Phenobarbital results in increased expression of SLC22A3 mRNA | increases expression | 19482888
|
D010646 |
Phentolamine |
Phentolamine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D010646 |
Phentolamine |
Phentolamine inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in increased expression of SLC22A3 mRNA | affects binding|increases activity|increases expression | 18489776
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of SLC22A3 mRNA | increases expression | 17426115
|
D011794 |
Quercetin |
Quercetin results in increased expression of SLC22A3 mRNA | increases expression | 18095365
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in decreased expression of SLC22A3 mRNA | decreases expression | 20106945
|
C052075 |
thioperamide |
thioperamide inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
C052075 |
thioperamide |
thioperamide inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
C005185 |
trimazosin |
trimazosin inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
C005185 |
trimazosin |
trimazosin inhibits the reaction [SLC22A3 protein results in increased uptake of 1-Methyl-4-phenylpyridinium] | decreases reaction|increases uptake | 12411423
|
D014415 |
Tunicamycin |
Tunicamycin results in increased expression of SLC22A3 mRNA | increases expression | 17127020
|
D014747 |
Vinblastine |
SLC22A3 protein affects the susceptibility to Vinblastine | affects response to substance | 16217747
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Phenobarbital |
7.42 | 6195326 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.42 | 15322242 11752688 14514962 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.30 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
2.88 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
4.05 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
4.05 | 11473722 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
2.50 | 6695378 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Phenobarbital |
15.76 | 17620307 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
15.76 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
15.76 | 16835633 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
2.72 | 11748828 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
4.00 | 17084956 |
MESH:D000799 |
Angioedema |
|
Acetaminophen |
3.58 | 10982225 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.82 | 19183758 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.63 | 15238619 |
MESH:D001249 |
Asthma |
|
Histamine |
3.82 | 16387687 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
4.71 | 15336622 |
MESH:D001321 |
Autistic Disorder |
|
Acetaminophen |
1.44 | 18445737 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
4.15 | 19761891 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
7.99 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
7.99 | 12125929 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.52 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
2.60 | 15746008 |
MESH:D001859 |
Bone Neoplasms |
|
Paclitaxel |
4.32 | 15867366 |
MESH:D001862 |
Bone Resorption |
|
bisphenol A |
3.63 | 11985600 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
3.59 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
bisphenol A |
3.59 | 17123778 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
3.59 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
3.59 | 16675129 18497071 12948864 17018787 19861407 17289903 14630087 17261762 |
MESH:D001943 |
Breast Neoplasms |
|
Paclitaxel |
3.59 | 16244791 16115903 15136595 11325840 16273361 18223236 18234424 18323546 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
3.59 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
3.59 | 20435547 |
MESH:D001986 |
Bronchial Spasm |
|
Histamine |
5.55 | 18298128 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
5.28 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
4.20 | 16111702 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
2.59 | 16835633 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Acetaminophen |
10.80 | 3084413 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
10.80 | 21507988 12619106 12907637 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
10.80 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Paclitaxel |
10.80 | 16313753 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Phenobarbital |
10.80 | 6705139 17173139 20935162 20007298 1701930 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
10.80 | 19519916 12508355 |
MESH:D002278 |
Carcinoma in Situ |
|
bisphenol A |
4.72 | 17123778 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.70 | 17234771 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vinblastine |
3.66 | 1485588 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
1.98 | 20419170 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
6.32 | 19794523 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
6.32 | 16120746 18850075 18670907 |
MESH:D002386 |
Cataract |
|
Acetaminophen |
2.43 | 10977129 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Cyclosporine |
5.98 | 12371664 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
5.98 | 18566989 |
MESH:D002493 |
Central Nervous System Diseases |
|
Phenobarbital |
3.99 | 4080065 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
2.94 | 16835633 |
MESH:D002779 |
Cholestasis |
|
Cyclosporine |
7.12 | 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.12 | 19176532 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
1.99 | 12621046 15340226 16354765 15668235 8697196 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
2.38 | 17191121 11134977 15741050 19056647 19440933 17148506 16640504 |
MESH:D015179 |
Colorectal Neoplasms |
|
Paclitaxel |
3.52 | 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
3.52 | 18852136 18095365 |
MESH:D015179 |
Colorectal Neoplasms |
|
Vinblastine |
3.52 | 18802399 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.84 | 17141729 14669216 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
1.24 | 20055451 15322242 10048152 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.30 | 18249437 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
3.52 | 19496084 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.61 | 17107852 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
3.19 | 19279558 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetaminophen |
3.30 | 10663392 14986274 10915739 19085960 10774834 19416960 19739265 19370779 14550746 11421492 12540782 18071297 11287661 11461765 11529661 12958197 2444490 16081117 19923254 15968718 19420014 16109766 17906064 12705907 12392966 17522070 11743745 16227642 11739529 16177239 14725611 16485898 12153990 12594235 18713872 16393943 15619225 17562736 16781746 19164858 11834606 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
3.30 | 20420201 |
MESH:D056487 |
Drug-Induced Liver Injury, Chronic |
|
Acetaminophen |
3.83 | 19426721 |
MESH:D004362 |
Drug Toxicity |
|
Lamivudine |
7.69 | 15040536 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
7.69 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.27 | 18367378 |
MESH:D004421 |
Dystonia |
|
Phenobarbital |
3.76 | 1851702 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.38 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.38 | 11000095 12711302 |
MESH:D004487 |
Edema |
|
thioperamide |
10.38 | 19703484 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
3.64 | 16714409 15322242 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
2.81 | 11473722 19148513 18566989 |
MESH:D004715 |
Endometriosis |
|
Mifepristone |
8.40 | 16134523 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
8.40 | 9294722 10568697 |
MESH:D004802 |
Eosinophilia |
|
Histamine |
4.79 | 12689652 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Phenobarbital |
3.85 | 3659116 |
MESH:D004828 |
Epilepsies, Partial |
|
Phenobarbital |
3.61 | 11558140 3922381 |
MESH:D004827 |
Epilepsy |
|
Phenobarbital |
2.76 | 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Phenobarbital |
3.32 | 6401628 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Phenobarbital |
3.99 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Phenobarbital |
3.76 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
4.41 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Paclitaxel |
4.41 | 16481741 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
2.82 | 11564622 |
MESH:D005234 |
Fatty Liver |
|
Cyclosporine |
11.70 | 19224547 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
11.70 | 17967931 19004024 18296743 19551842 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
11.70 | 20131406 19236843 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.20 | 11858732 |
MESH:D005355 |
Fibrosis |
|
Cyclosporine |
19.03 | 12639820 12168785 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
19.03 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
19.03 | 19474275 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
19.03 | 20067830 |
MESH:D005756 |
Gastritis |
|
Acetaminophen |
3.41 | 16983495 |
MESH:D005885 |
Gingival Hyperplasia |
|
Cyclosporine |
3.95 | 8708960 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
3.22 | 19804834 |
MESH:D005910 |
Glioma |
|
Quercetin |
2.95 | 17643826 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.33 | 10696789 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.99 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
5.99 | 10048152 11294989 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.38 | 20558911 |
MESH:D006457 |
Hemoglobinuria, Paroxysmal |
|
Cyclosporine |
4.16 | 15720958 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.10 | 11000095 |
MESH:D006509 |
Hepatitis B |
|
Lamivudine |
4.86 | 17703166 |
MESH:D019694 |
Hepatitis B, Chronic |
|
Lamivudine |
4.86 | 16476009 15631357 12044531 15274664 15309715 |
MESH:D006529 |
Hepatomegaly |
|
Phenobarbital |
12.89 | 16109766 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
12.89 | 16221962 19772884 18467677 19176532 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
12.89 | 12621046 16120746 15340226 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.76 | 15709030 |
MESH:D015658 |
HIV Infections |
|
Lamivudine |
3.62 | 9296927 11141242 17530837 20032539 |
MESH:D006689 |
Hodgkin Disease |
|
Vinblastine |
3.82 | 18180244 18501091 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
3.49 | 17088409 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.78 | 16959395 18606429 8697196 15340226 16354765 |
MESH:D006930 |
Hyperalgesia |
|
Acetaminophen |
2.50 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.36 | 21332399 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
8.49 | 20558911 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
8.49 | 11834736 18262572 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.37 | 21332399 |
MESH:D006973 |
Hypertension |
|
Cyclosporine |
7.98 | 10903974 |
MESH:D006973 |
Hypertension |
|
Quercetin |
7.98 | 18356687 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
7.98 | 18670907 18850075 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
4.47 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.47 | 12878042 12200463 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
4.24 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
bisphenol A |
16.24 | 16393666 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
16.24 | 11836018 18457598 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
16.24 | 16393666 16627594 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
16.24 | 16306350 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
3.10 | 16580747 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.70 | 17086741 |
MESH:D007638 |
Keratoconjunctivitis Sicca |
|
Cyclosporine |
4.17 | 15604871 |
MESH:D007674 |
Kidney Diseases |
|
Acetaminophen |
13.19 | 12587719 15629191 |
MESH:D007674 |
Kidney Diseases |
|
Cyclosporine |
13.19 | 18776723 10903974 8314463 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
13.19 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
13.19 | 16962696 |
MESH:D007680 |
Kidney Neoplasms |
|
Cyclosporine |
6.57 | 12371664 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
6.57 | 15610895 |
MESH:D007938 |
Leukemia |
|
Quercetin |
3.03 | 17468513 |
MESH:D008080 |
Liposarcoma |
|
Paclitaxel |
4.58 | 17353645 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
6.18 | 18296743 |
MESH:D008103 |
Liver Cirrhosis |
|
Phenobarbital |
6.18 | 21047994 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
4.66 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
4.66 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
4.66 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
4.66 | 12878042 |
MESH:D008107 |
Liver Diseases |
|
Acetaminophen |
3.70 | 12969438 16611625 19014921 11587558 19784758 19460945 16610002 12587719 |
MESH:D008107 |
Liver Diseases |
|
Phenobarbital |
3.70 | 19363144 |
MESH:D017114 |
Liver Failure, Acute |
|
Acetaminophen |
3.01 | 17185352 16871587 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
16.65 | 15890375 9163691 18177683 2125692 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
16.65 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Phenobarbital |
16.65 | 21047994 19812893 8742319 19073162 19482888 15975961 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
16.65 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
16.65 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
16.65 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
12.79 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Phenobarbital |
12.79 | 1399818 6150874 18308698 2563599 17172636 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
12.79 | 19519916 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
12.79 | 12151625 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
4.57 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
4.57 | 20464547 20064080 18520028 20135361 18569708 20869020 18816296 17053015 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
4.57 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
4.57 | 19555203 11884234 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Paclitaxel |
3.88 | 14749477 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Corticosterone |
5.79 | 12807724 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
5.79 | 17203775 11408345 16891317 11807958 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
4.22 | 19453300 |
MESH:D008545 |
Melanoma |
|
Histamine |
5.23 | 17709802 |
MESH:D008545 |
Melanoma |
|
Paclitaxel |
5.23 | 12025231 12040289 16342250 |
MESH:D008545 |
Melanoma |
|
Vinblastine |
5.23 | 16432458 16248763 15577323 17761969 18176117 16809738 18332650 15577320 12374674 18505091 |
MESH:D008546 |
Melanoma, Experimental |
|
Acetaminophen |
3.31 | 19513568 |
MESH:D008664 |
Metal Metabolism, Inborn Errors |
|
Cyclosporine |
4.52 | 16801185 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
2.99 | 16381670 |
MESH:D009101 |
Multiple Myeloma |
|
Paclitaxel |
3.50 | 14749477 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.25 | 16239165 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.36 | 19151258 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
5.36 | 19595682 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.81 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
13.04 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
13.04 | 16411023 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
13.04 | 19207477 |
MESH:D020191 |
Myoclonic Epilepsies, Progressive |
|
Phenobarbital |
4.21 | 17484760 |
MESH:D009362 |
Neoplasm Metastasis |
|
Paclitaxel |
3.15 | 15867366 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
7.48 | 11141357 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
7.48 | 17405874 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
7.48 | 15185748 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
3.47 | 17289903 |
MESH:D009402 |
Nephrosis, Lipoid |
|
Cyclosporine |
4.17 | 17954296 |
MESH:D009404 |
Nephrotic Syndrome |
|
Cyclosporine |
3.06 | 18481113 19348381 |
MESH:D009410 |
Nerve Degeneration |
|
1-Methyl-4-phenylpyridinium |
4.84 | 17433543 |
MESH:D009421 |
Nervous System Malformations |
|
bisphenol A |
14.90 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
14.90 | 16427766 11399458 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
14.90 | 14600291 |
MESH:D019636 |
Neurodegenerative Diseases |
|
1-Methyl-4-phenylpyridinium |
8.11 | 16353238 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Acetaminophen |
8.11 | 18514411 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
4.12 | 17929310 |
MESH:D009503 |
Neutropenia |
|
Vinblastine |
4.33 | 17378895 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.20 | 18457598 17217161 11836018 20518802 19632207 20132043 16723640 21332399 18674790 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.20 | 20558911 |
MESH:D010014 |
Osteolysis |
|
Paclitaxel |
4.72 | 15867366 |
MESH:D010018 |
Osteomalacia |
|
Phenobarbital |
4.10 | 17016548 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
3.98 | 19495926 |
MESH:D010049 |
Ovarian Diseases |
|
bisphenol A |
4.72 | 11985600 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
10.66 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Mifepristone |
10.66 | 16525653 |
MESH:D010051 |
Ovarian Neoplasms |
|
Paclitaxel |
10.66 | 11161223 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
10.66 | 19005980 |
MESH:D010146 |
Pain |
|
Acetaminophen |
2.19 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Phenobarbital |
5.10 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
5.10 | 16965848 |
MESH:D010300 |
Parkinson Disease |
|
1-Methyl-4-phenylpyridinium |
4.04 | 17433543 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
3.98 | 12520081 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.31 | 18163543 |
MESH:D011230 |
Precancerous Conditions |
|
Cyclosporine |
14.06 | 12371664 |
MESH:D011230 |
Precancerous Conditions |
|
Phenobarbital |
14.06 | 2563599 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
14.06 | 19056647 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
bisphenol A |
8.63 | 10548101 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
8.63 | 11118676 11399792 11896295 11222880 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
bisphenol A |
9.77 | 20887781 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
9.77 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
marker/mechanism |
|
| 17173048 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
1.89 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
bisphenol A |
1.89 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
1.89 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
Paclitaxel |
1.89 | 17136230 16356831 16729912 17172428 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
1.89 | 14715546 17292933 |
MESH:D019310 |
Pseudolymphoma |
|
Phenobarbital |
4.23 | 12752131 |
MESH:D011565 |
Psoriasis |
|
Cyclosporine |
2.14 | 16882103 |
MESH:D011629 |
Puberty, Precocious |
|
bisphenol A |
4.52 | 10548101 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.26 | 19058328 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.59 | 18990726 |
MESH:D012206 |
Rhabdomyolysis |
|
Lamivudine |
5.27 | 9296927 |
MESH:D012220 |
Rhinitis |
|
Histamine |
4.75 | 12689652 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
5.28 | 16862918 |
MESH:D012640 |
Seizures |
|
Phenobarbital |
2.52 | 3137016 4039156 11442880 16876388 |
MESH:D003294 |
Seizures, Febrile |
|
Phenobarbital |
4.56 | 6407741 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
5.06 | 19755658 10029692 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
5.06 | 16192470 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
2.52 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Paclitaxel |
2.52 | 18396642 18506536 |
MESH:D019966 |
Substance-Related Disorders |
|
bisphenol A |
3.72 | 16045194 16684133 |
MESH:D024801 |
Tauopathies |
|
Paclitaxel |
4.55 | 16930453 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.64 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
Phenobarbital |
2.86 | 1399818 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
4.42 | 19048282 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
4.81 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
4.81 | 16720314 |
MESH:D014581 |
Urticaria |
|
Acetaminophen |
8.32 | 10982225 |
MESH:D014581 |
Urticaria |
|
Histamine |
8.32 | 18298128 |
MESH:D014591 |
Uterine Diseases |
|
bisphenol A |
4.74 | 14652134 |
MESH:D014605 |
Uveitis |
|
Cyclosporine |
3.72 | 1336536 |
MESH:D014625 |
Vaginal Neoplasms |
|
Vinblastine |
4.79 | 15577323 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.33 | 12125929 |
MESH:D020301 |
Vasospasm, Intracranial |
|
Papaverine |
6.32 | 19057314 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
3.98 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.52 | 16723640 |
MESH:D014985 |
Xerophthalmia |
|
Cyclosporine |
4.17 | 17120751 |